The novel catecholaminergic and serotoninergic activity enhancer R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes
- 3 June 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 328 (3) , 205-208
- https://doi.org/10.1016/s0304-3940(02)00461-5
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Selegiline and Desmethylselegiline Stimulate NGF, BDNF, and GDNF Synthesis in Cultured Mouse AstrocytesBiochemical and Biophysical Research Communications, 2000
- The Transforming Growth Factor‐βsJournal of Neurochemistry, 2000
- GDNF and NT-4 Protect Midbrain Dopaminergic Neurons from Toxic Damage by Iron and Nitric OxideExperimental Neurology, 2000
- (−)1-(Benzofuran-2-yl)-2-propylaminopentane Shows Survival Effect on Cortical Neurons Under Serum-Free Condition Through Sigma ReceptorsCellular and Molecular Neurobiology, 2000
- (−)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brainBritish Journal of Pharmacology, 1999
- Differential effects of GDNF and BDNF on cultured ventral mesencephalic neuronsMolecular Brain Research, 1999
- Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medicationLife Sciences, 1995
- Neurotrophic factors: from molecule to manTrends in Neurosciences, 1994
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993
- BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigraNature, 1991